Swedish Orphan Biovitrum AB (publ)

Stockholm Stock Exchange:SOBI.ST

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

Sweden

Market Cap

USD 9.84 B

Share Price

USD 28.56

Avg Daily Volume

295,687

Change (1 day)

1.05%

Change (1 year)

-0.85%

Change (YTD)

-0.36%

Swedish Orphan Biovitrum AB (publ) EBIT Margin for the year ending December 31, 2024: 21.61%

Swedish Orphan Biovitrum AB (publ) EBIT Margin is 21.61% for the year ending December 31, 2024, a 17.62% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Swedish Orphan Biovitrum AB (publ) EBIT Margin for the year ending December 31, 2023 was 18.37%, a -8.66% change year over year.
Swedish Orphan Biovitrum AB (publ) EBIT Margin for the year ending December 31, 2022 was 20.12%, a -15.89% change year over year.
Swedish Orphan Biovitrum AB (publ) EBIT Margin for the year ending December 31, 2021 was 23.92%, a -22.41% change year over year.
Swedish Orphan Biovitrum AB (publ) EBIT Margin for the year ending December 31, 2020 was 30.82%, a -2.56% change year over year.